JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2024
JACOBIO-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
JACOBIO-B: (1) INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024;(2) RESIGNATION OF NON-EXECUTIVE DIRECTOR; AND(3) CHANGE IN THE COMPOSITION OF THE REMUNERATIONCOMMITTEE AND THE NOMINATION COMMITTEE
JACOBIO-B: INSIDE INFORMATION - JACOBIO ANNOUNCES EXCLUSIVE LICENSING-OUT AGREEMENT WITH ALLIST FOR GLECIRASIB AND JAB-3312
JACOBIO-B: SUPPLEMENTAL ANNOUNCEMENTTO THE 2023 INTERIM REPORT AND THE 2023 ANNUAL REPORT
JACOBIO-B: DATE OF BOARD MEETING
JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO COMPLETED FIRST PATIENT DOSAGE IN THE PHASE III CLINICAL TRIAL OF JAB-3312 IN COMBINATION WITH GLECIRASIB
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2024
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2024
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
No Data
No Data